Invesco Dorsey Wright SmallCap Momentum ETF (DWAS)
| Assets | $396.63M |
| Expense Ratio | 0.60% |
| PE Ratio | 23.83 |
| Shares Out | 3.93M |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.00% |
| Ex-Dividend Date | Sep 22, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 0.11% |
| Volume | 12,063 |
| Open | 120.52 |
| Previous Close | 120.90 |
| Day's Range | 118.47 - 120.52 |
| 52-Week Low | 81.43 |
| 52-Week High | 127.77 |
| Beta | 1.13 |
| Holdings | 203 |
| Inception Date | Jul 19, 2012 |
About DWAS
Fund Home PageThe Invesco Dorsey Wright SmallCap Momentum ETF (DWAS) is an exchange-traded fund that is based on the Dorsey Wright SmallCap Tech Leaders index. The fund tracks an index of 200 small-cap securities with the best relative strength indicators, these indicators are determined by Dorsey Wright's proprietary methodology. DWAS was launched on Jul 19, 2012 and is issued by Invesco.
Top 10 Holdings
13.55% of assets| Name | Symbol | Weight |
|---|---|---|
| Sezzle Inc. | SEZL | 1.91% |
| Erasca, Inc. | ERAS | 1.67% |
| agilon health, inc. | AGL | 1.50% |
| Tango Therapeutics, Inc. | TNGX | 1.38% |
| Enova International, Inc. | ENVA | 1.31% |
| Bel Fuse Inc. | BELFB | 1.26% |
| Graham Corporation | GHM | 1.22% |
| MYR Group Inc. | MYRG | 1.14% |
| Climb Bio, Inc. | CLYM | 1.13% |
| Amneal Pharmaceuticals, Inc. | AMRX | 1.03% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2025 | $0.00533 | Sep 26, 2025 |
| Jun 23, 2025 | $0.010 | Jun 27, 2025 |
| Mar 24, 2025 | $0.05242 | Mar 28, 2025 |
| Dec 23, 2024 | $0.07307 | Dec 27, 2024 |
| Sep 23, 2024 | $0.51459 | Sep 27, 2024 |
| Jun 24, 2024 | $0.08212 | Jun 28, 2024 |
Performance
DWAS had a total return of 40.29% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.20%.
News
ETF flows in July point to a more balanced stock-market rally as mid- and small-cap funds start to outperform first-half winners
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at flows into U.S. exchange-traded funds in July which recorded their second-best mon...
One group of small-cap stocks could outperform, Oppenheimer says
Small caps surged to begin the week. A small slice of the group could continue to outperform, says Oppenheimer's Ari Wald.